Found: 95
Select item for more details and to access through your institution.
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 10, p. 1783, doi. 10.1007/s00432-014-1715-2
- By:
- Publication type:
- Article
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment.
- Published in:
- Medical Physics, 2018, v. 45, n. 4, p. 1360, doi. 10.1002/mp.12804
- By:
- Publication type:
- Article
Advanced-Metastatic Non-Small-Cell Lung Cancer EGFR-mutated in Italy: patient management costs and potential productivity losses.
- Published in:
- Global & Regional Health Technology Assessment, 2019, v. 2019, p. 1, doi. 10.1177/2284240319877892
- By:
- Publication type:
- Article
Diagnostic and therapeutic issues for patients with advanced non-small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (Review).
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 2, p. 509, doi. 10.3892/ijo.2014.2453
- By:
- Publication type:
- Article
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 16, p. 3951, doi. 10.3390/ijms20163951
- By:
- Publication type:
- Article
Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence.
- Published in:
- Current Oncology, 2022, v. 29, n. 1, p. 255, doi. 10.3390/curroncol29010024
- By:
- Publication type:
- Article
Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 3384, doi. 10.3390/curroncol28050292
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Second-Line Treatment Options in Non-Small-Cell Lung Cancer: Report From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Evolving Role of Nivolumab in Non-Small-Cell Lung Cancer for Second-Line Treatment: A New Cornerstone for Our Treatment Algorithms. Results From an International Experts Panel Meeting of the Italian Association of Thoracic Oncology.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Treatment of Unfit Patients With Advanced Non-Small-Cell Lung Cancer: Definition Criteria According an Expert Panel.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Treatment of Elderly Patients With Non-Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Treatment of Elderly Patients With Non--Small-Cell Lung Cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 5, p. 325, doi. 10.1016/j.cllc.2015.02.006
- By:
- Publication type:
- Article
Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 418, doi. 10.1016/j.cllc.2014.06.007
- By:
- Publication type:
- Article
Management of Italian Patients With Advanced Non-Small-Cell Lung Cancer After Second-Line Treatment: Results of the Longitudinal Phase of the LIFE Observational Study.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 5, p. 338, doi. 10.1016/j.cllc.2014.04.004
- By:
- Publication type:
- Article
Management of Nonhematologic Toxicities Associated With Different EGFR-TKIs in Advanced NSCLC: A Comparison Analysis.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 4, p. 307, doi. 10.1016/j.cllc.2014.04.006
- By:
- Publication type:
- Article
Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: results of an international expert panel meeting of the Italian Association of Thoracic Oncology.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Treatment of Advanced Non--Small-Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation or ALK Gene Rearrangement: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 3, p. 173, doi. 10.1016/j.cllc.2013.12.002
- By:
- Publication type:
- Article
Treatment, Rationale, and Study Design of TALISMAN Study: A Randomized Phase II Open-Label Study of Second-line Erlotinib Versus Intermittent Erlotinib Dosing With Docetaxel in the Treatment of Former-Smoker Men Affected by Recurrent Squamous Non-Small-Cell Lung Cancer
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 1, p. 70, doi. 10.3816/CLC.2011.n.010
- By:
- Publication type:
- Article
What Matters Most to Lung Cancer Patients? A Qualitative Study in Italy and Belgium to Investigate Patient Preferences.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.602112
- By:
- Publication type:
- Article
Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies.
- Published in:
- Lung Cancer: Targets & Therapy, 2019, v. 10, p. 125, doi. 10.2147/LCTT.S209231
- By:
- Publication type:
- Article
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42900-4
- By:
- Publication type:
- Article
Lung cancer surgery in oligometastatic patients: outcome and survival.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2020, v. 57, n. 6, p. 1173, doi. 10.1093/ejcts/ezaa005
- By:
- Publication type:
- Article
Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2017, v. 52, n. 5, p. 975, doi. 10.1093/ejcts/ezx122
- By:
- Publication type:
- Article
Lung Tissue Injury as an Atypical Response to Nivolumab in Non-Small Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
EGFR-TKI Plus Anti-Angiogenic Drugs in EGFR-Mutated Non–Small Cell Lung Cancer: A Meta-Analysis of Randomized Clinical Trials.
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 6, p. 1, doi. 10.1093/jncics/pkaa064
- By:
- Publication type:
- Article
Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4476, doi. 10.3390/jcm13154476
- By:
- Publication type:
- Article
Surgically Treated pT2aN0M0 (Stage IB) Non-Small Cell Lung Cancer: A 20-Year Single-Center Retrospective Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 5, p. 2081, doi. 10.3390/jcm12052081
- By:
- Publication type:
- Article
Application of nnU-Net for Automatic Segmentation of Lung Lesions on CT Images and Its Implication for Radiomic Models.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 24, p. 7334, doi. 10.3390/jcm11247334
- By:
- Publication type:
- Article
Preliminary Results of Robotic Lobectomy in Stage IIIA-N2 NSCLC after Induction Treatment: A Case Control Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3465, doi. 10.3390/jcm10163465
- By:
- Publication type:
- Article
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer.
- Published in:
- Oncogene, 2003, v. 22, n. 23, p. 3548, doi. 10.1038/sj.onc.1206419
- By:
- Publication type:
- Article
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs".
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2877, doi. 10.3390/cancers16162877
- By:
- Publication type:
- Article
Revamping Non-Small Cell Lung Cancer Treatments in Stages II and III: Preparing Healthcare for Cutting-Edge Immuno-Oncology Regimens.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2842, doi. 10.3390/cancers16162842
- By:
- Publication type:
- Article
Post-Progression Analysis of EGFR -Mutant NSCLC Following Osimertinib Therapy in Real-World Settings.
- Published in:
- Cancers, 2024, v. 16, n. 14, p. 2589, doi. 10.3390/cancers16142589
- By:
- Publication type:
- Article
Alectinib vs. Lorlatinib in the Front-Line Setting for ALK-Rearranged Non-Small-Cell Lung Cancer (NSCLC): A Deep Dive into the Main Differences across ALEX and CROWN Phase 3 Trials.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2457, doi. 10.3390/cancers16132457
- By:
- Publication type:
- Article
Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art.
- Published in:
- Cancers, 2024, v. 16, n. 7, p. 1331, doi. 10.3390/cancers16071331
- By:
- Publication type:
- Article
New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5079, doi. 10.3390/cancers15205079
- By:
- Publication type:
- Article
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4779, doi. 10.3390/cancers15194779
- By:
- Publication type:
- Article
Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4553, doi. 10.3390/cancers15184553
- By:
- Publication type:
- Article
The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2476, doi. 10.3390/cancers15092476
- By:
- Publication type:
- Article
Upfront Advanced Radiotherapy and New Drugs for NSCLC Patients with Synchronous Brain Metastases: Is the Juice Worth the Squeeze? A Real-World Analysis from Lombardy, Italy.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1103, doi. 10.3390/cancers15041103
- By:
- Publication type:
- Article
Rescue Surgery after Immunotherapy/Tyrosine Kinase Inhibitors for Initially Unresectable Lung Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2661, doi. 10.3390/cancers14112661
- By:
- Publication type:
- Article
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 2935, doi. 10.3390/cancers13122935
- By:
- Publication type:
- Article
Genomic Characterization of Concurrent Alterations in Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Mutations.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2172, doi. 10.3390/cancers13092172
- By:
- Publication type:
- Article